The Children's Healthcare of Atlanta - Egleston Hospital is a nationally ranked, freestanding, 295-bed, pediatric acute care children's hospital located in Atlanta, Georgia.

There are 295 beds in Children's Healthcare of Atlanta / Emory University.

During the past decade, Children's Healthcare of Atlanta / Emory University conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 18 clinical trials were completed, i.e. on average, 45% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 8 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Children's Healthcare of Atlanta / Emory University" #1 sponsor was "Emory University" with 9 trials, followed by "Therapeutic Advances in Childhood Leukemia Consortium" with 9 trials sponsored, "Arbor Research Collaborative for Health" with 4 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored and "American Thrombosis and Hemostasis Network" with 4 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Children's Healthcare of Atlanta / Emory University" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 9 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "Children's Healthcare of Atlanta" with 5 trials as a collaborator, "Cystic Fibrosis Foundation" with 4 trials as a collaborator and "Emory University" with 4 trials as a collaborator. Other collaborators include 110 different institutions and companies that were collaborators in the rest 91 trials.

According to Clinical.Site data, the most researched conditions in "Children's Healthcare of Atlanta / Emory University" are "Acute Liver Failure" (4 trials), "Biliary Atresia" (4 trials), "Cystic Fibrosis" (4 trials), "Lymphoblastic Leukemia, Acute, Childhood" (4 trials) and "Sickle Cell Disease" (4 trials). Many other conditions were trialed in "Children's Healthcare of Atlanta / Emory University" in a lesser frequency.

Most popular intervention types in "Children's Healthcare of Atlanta / Emory University" are "Drug" (41 trials), "Biological" (6 trials), "Other" (6 trials), "Procedure" (4 trials) and "Behavioral" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (6 trials), "Methotrexate" (6 trials), "Placebo" (6 trials), "Cyclophosphamide" (3 trials) and "Etoposide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Children's Healthcare of Atlanta / Emory University" are 75 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Children's Healthcare of Atlanta / Emory University". undefined are not yet recruiting, 22 are recruiting, 7 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 31 completed trials in Children's Healthcare of Atlanta / Emory University, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Children's Healthcare of Atlanta / Emory University, 23 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".